Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
FDA Looks Ahead To Complex Product-Specific Guidances
Exploring The US FDA's Upcoming Complex Generic Product-Specific Guidance Lists
Apr 28 2020
•
By
Derrick Gingery
The US FDA issued more revised than new product-specific guidances for generic products in fiscal year 2019, unlike past fiscal years • Source: Shutterstock
More from Generics
More from Products